Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.

Webinar presenter Jeffrey Gregg, MD, University of Nevada

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Video Spotlight

Troubleshooting QC Errors with Unity Next Peer QC

Laboratory QC errors can impact patient results and significantly increase healthcare expenses. Your lab can minimize errors, provide more reliable patient results, and avoid costly reruns with Unity Next Peer QC. Explore how your lab can increase reliability in test results by comparing QC results with over 38,000 peers and resolve issues quickly by accessing peer reports on-demand. To Learn more/Watch now click here.

Discover the Agilent CDx Digital Education Portal

The CDx Digital Education Portal, your gateway to centralized and comprehensive companion diagnostic (CDx) learning from Agilent. Find everything you need to master your command of Agilent CDx assays and biomarker interpretation, all in one place. Learn More.

Transforming Oncology with Illumina Genomics

Researchers from the Ontario Institute for Cancer Research and United Health Network share how knowing more about cancer biology through genomic studies is enabling universities and health systems to advance the fight against cancer. LEARN MORE.

Discover the Next-Generation Atlas of Stains from Agilent

Discover the Next-Generation Atlas of Stains from Agilent, a pathology training platform for enhancing your PD-L1 evaluation skills. Explore a repository of real-world cases spanning the full range of PD-L1 expression and unlock a comprehensive suite of PD-L1 evaluation tools. Learn More.

Award-winning Histology Slide Printer

Epredia’s SlideMate Laser provides high-resolution, 600-dpi laser printing on microscope slides. Laser technology, along with specialty slides, create indelible markings that can enhance traceability throughout the life of the slide. Learn More.

PrestoCHILL for Standardized, High-Quality Frozen Sections

SEE IT IN ACTION: NSH BOOTH #515. PrestoCHILL combines a patented “face-down” embedding technique with a programmable -40°C cooling chamber to rapidly process quality frozen sections of any tissue type. With PrestoCHILL, it is finally possible to create standardized high quality frozen slides. LEARN MORE.